MS vs PRCT · P/E 20, $344.27B cap vs rev $224.5M
Morgan Stanley (MS) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
MS currently screens at market cap $344.27B and trailing P/E 19.8. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the MS and PRCT stock pages for the full models.
Not investment advice.